Specific immunotherapy has long‐term preventive effect of seasonal and perennial asthma: 10‐year follow‐up on the PAT study

Jacobsen, L.; Niggemann, B.; Dreborg, S.; Ferdousi, H. A.; Halken, S.; Høst, A.; Koivikko, A.; Norberg, L. A.; Valovirta, E.; Wahn, U.; Möller, C.; (The PAT investigator group)

doi:10.1111/j.1398-9995.2007.01451.x

Specific immunotherapy has long‐term preventive effect of seasonal and perennial asthma: 10‐year follow‐up on the PAT study

Background: 3‐year subcutaneous specific immunotherapy (SIT) in children with seasonal allergic rhinoconjunctivitis reduced the risk of developing asthma during treatment and 2 years after discontinuation of SIT (5‐year follow‐up) indicating long‐term preventive effect of SIT. Objective: We evalu…